2012
DOI: 10.1016/j.tet.2012.03.050
|View full text |Cite
|
Sign up to set email alerts
|

A facile and rapid one-step synthesis of 8-substituted xanthine derivatives via tandem ring closure at room temperature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
12
0
4

Year Published

2012
2012
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 43 publications
0
12
0
4
Order By: Relevance
“…In spite of broader pharmaceutical applications and similarity to purine family, xanthine‐based research has not taken up full measure thus limiting synthesis of xanthine‐based molecules (Monteiro et al, 2016). The most noticeable reason for this is adverse synthetic procedures such as ring closure and condensation method for the production of new products (Allwood et al, 2007; Bandyopadhyay et al, 2012; Chen et al, 2014; Hayallah et al, 2002; Kim et al, 2010; Lee et al, 2016; Sakai et al, 1992;). In terms of xanthine‐based drug development, large scale synthesis is not supported thus there is crucial need for the development of feasible synthetic methods so that new xanthine‐based drug candidates can be introduced.…”
Section: Introductionmentioning
confidence: 99%
“…In spite of broader pharmaceutical applications and similarity to purine family, xanthine‐based research has not taken up full measure thus limiting synthesis of xanthine‐based molecules (Monteiro et al, 2016). The most noticeable reason for this is adverse synthetic procedures such as ring closure and condensation method for the production of new products (Allwood et al, 2007; Bandyopadhyay et al, 2012; Chen et al, 2014; Hayallah et al, 2002; Kim et al, 2010; Lee et al, 2016; Sakai et al, 1992;). In terms of xanthine‐based drug development, large scale synthesis is not supported thus there is crucial need for the development of feasible synthetic methods so that new xanthine‐based drug candidates can be introduced.…”
Section: Introductionmentioning
confidence: 99%
“…при лікуванні астми, бронхіту і хронічної об структивної хвороби легень. Також похідні ксантину знайшли застосування як ді уретики, аналгетики, серцеві стимулятори, протизапальні, психотропні й ниркові за хисні агенти [2][3][4][5].…”
unclassified
“…Масспектр 1бензил8тіотеоброміну (2) (m/z 1%): 303 (21,6), 302 (93,3), 301 (31,5), 285 (6,5), 211 (20,0), 210 (6,0), 197 (5,8), 169 (7,3), 168 (7,0), 152 (20,5), 149 (6,3), 141 (6,0), 132 (7,2), 111 (38,7), 110 (11,2), 99 (22,9), 98 (9,3), 92 (6,7), 91 (99, 9), 90 (30,2), 85 (5,5), 83 (10,5), 82 (9,9), 81 (6,4), 77 (8,6), 70 (20,4), 69 (12,2), 67 (16,4), 65 (14, 9), 55 (7,2), 43 (11,5), 42 (11,6), 41 (8,7). (3)(4)(5)(6)(7)(8).…”
unclassified
See 2 more Smart Citations